STONKWHISPER
← Back to Intel
Insider ActivityIRD

Foundation Fighting Blindness Retinal Degeneration Fund, Director at Opus Genetics, Inc., sold $7.4M of IRD

Updated Jun 7, 2026
Foundation Fighting Blindness Retinal Degeneration Fund Director
Opus Genetics, Inc. · $IRD
$7.4M Total Value
1,700,000 Shares Traded
$4.35 Price / Share
3,792,171 Shares Owned After
2026-05-20 Filing Date

Transaction Details

InsiderFoundation Fighting Blindness Retinal Degeneration Fund
TitleDirector
CompanyOpus Genetics, Inc.
TickerIRD
Transaction TypeSale
Transaction Date2026-05-18
Shares Traded1,700,000
Price Per Share$4.35
Total Value$7.4M
Filed Date2026-05-20
Accession Number0002042266-26-000001

Ownership Context

Shares Owned After Transaction3,792,171
Ownership TypeDirect

SEC Filing

↗ View Original SEC Filing

Accession: 0002042266-26-000001

Other Insider Trades — IRD

Full Ticker Profile

View all insider trades, dark pool activity, congressional filings, and the Whisper Score for IRD — Opus Genetics, Inc. →

Track IRD insider activity in real time on The Wire →

Get alerts when Foundation Fighting Blindness Retinal Degeneration Fund files new trades — Go Pro →

Data sourced from SEC Form 4 insider trading filings. Transaction details are as reported to the Securities and Exchange Commission. This page does not constitute financial advice. StonkWhisper presents public records — it does not verify or guarantee the accuracy of SEC filings.

Last updated: June 07, 2026 at 07:06 UTC

Want real-time data? Access The Wire for live sentiment tracking.